SecBot SecBot
SECBOTREPLAY Home › Report › HALO

HALO · CEO Helen Torley sold $153K in stock after exercising derivative shares…

HALOZYME THERAPEUTICS, INC. · CLUSTER filed Jul 9, 2026 at 17:19 ET

At the news

NEUTRALIMPACT 2/10

CLUSTER filed Jul 9, 2026 at 17:19 ET

CEO Helen Torley sold $153K in stock after exercising derivative shares at $12.07, netting a substantial cashless-settlement gain. Director Bernadette Connaughton also sold $76K. The $229K total open-market sales represent ~0.002% of HALO's $9.5B market cap, well below any materiality threshold. The CEO's sales are consistent with routine tax-settlement and diversification, not a bearish signal.

  • CEO Torley exercised 1,923 derivative shares at $12.07 and simultaneously sold 1,923 shares ($153K total) at ~$80, a classic cashless exercise pattern
  • Director Connaughton sold 1,000 shares at $76.39 for $76K
  • Total open-market sales of $229K equal ~0.002% of $9.5B market cap
  • Prior 30-day insider activity showed $278K in sales, this cluster is a continuation of routine, small-dollar selling

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access